Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
gene therapy
life sciences
national blog main
national top stories
novartis
3
×
zolgensma
3
×
biotech
deals
fda
medicaid
national
new york top stories
roche
spark therapeutics
spinal muscular atrophy
achromatopsia
acquisitions
advanced therapies
atmp
avexis
beta-thalassemia
bill cassidy
billy dunn
biogen
bioprocess insider
bluebird bio
bms
boston blog main
boston top stories
brammer bio
bristol-myers squibb
cancer
car-t
car-t chimeric antigen receptor
catalent
cell & gene
cell gene therapy
cell therapeutics
cell therapies
What
therapy
3
×
gene
access
advanced
age
approved
atrophy
bigger
biggest
capacity
car
cell
come
consolidation
crispr
daily
deal
drug
emerging
evrysdi
falcon
fda
focus
friday
gave
green
home
intended
j
johnson
lights
liquid
medicine
meiragtx
milestones
morning
muscular
new
oral
past
Language
unset
Current search:
therapy
×
novartis
×
zolgensma
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy